
This audio is automatically created. Please let me know if there is feedback.
Danone is releasing OIKOS yogurt drinks for Ozempic and other GLP-1 drugs, trying to strengthen its popular brands as a tool for consumers to support nutritional demand while taking drugs.
The Oikos Fusion aims for about 10%of the US population, which consumers try to build and maintain muscle mass and try or use GLP-1 drugs. Danone quotes data from American Lifestyle Medicine, saying that one-fifth of the consumer is muscle while taking GLP-1 drugs.
RAFAEL ACEDO, chairman of Danone North America, said that many company brands, including Oikos, have already benefited from consumers who are already taking GLP-1 drugs, but they have the opportunity to launch products that are focused on building and maintaining muscles.
Acevedo said in an interview, “We see it as a unique opportunity.” GLP-1 is the center of the Bullseye of this proposal. “
Danone, Chobani and other yogurt manufacturers were one of the biggest beneficiaries, while paying more attention to eating and drinking consumers. GLP-1 drugs also inhibit appetite so that consumers are forced to find smaller parts packaged in nutrition.
Oikos Fusion Cultured Dairy products in Paris are also active and more extensively appealing to consumers who want to maintain muscles. This includes patented mixtures of rheum, rheumin and vitamin D, and is designed to support muscle mass and maintenance and digestive health. It is increasingly important among those who try to lose weight or want to improve their intestinal health.
The company started working at Oikos Fusion a year ago. Danone finds that after discovering that 2-3 grams of lysine can be operated with a complete protein and vitamin D of the appropriate amount, it can be operated as an appropriate amount of complete protein and vitamin D to cause muscle synthesis, especially after discovering the process of using and restoring muscle protein when pairing with a balanced diet and exercise. Settled in the combination.
Acevedo said the formula had already existed in another part of Danone’s professional nutrition business. We support muscle health and maintenance during weight loss. The company saw the opportunity to take advantage of that knowledge to bring it to another part of the business.
OIKOS Fusion will be released nationwide in October in Walmart’s refrigeration area this month in Target, Kroger and WakeFern.
Each seven ounces of Oikos Fusion contain 23 grams of complete protein and 5 grams of prebio tick fibers, which helps to supply “good” bacteria in the intestines and vitamins B3 and B12 to convert food into energy. It is provided with strawberry, mixed berry and vanilla flavor.
OIKOS FUSION is the latest major innovation of the rapidly growing Danone brand, with a 40% increase in retail sales in 2024, and annual sales for the first time. Danone decided to launch muscle construction products according to Oikos rather than creating a completely new brand.
“We think that it actually matches the meaning of the brand.
Earlier this year, dairy products I entered the protein shakake market worth $ 7 billion. Oikos protein is shaken to take advantage of functional demand for nutrition on the go. This is the first anti -non -prevention option in the market for one of Danone’s yogurt brand.